| Ytd | -22.44% | |
| 1y | -57.52% |
| Open | 0.46 | Prev Close | 0.46 | Low | 0.43 | High | 0.47 | Mkt Cap | 10.75M |
| Vol | 572.59K | Avg Vol | 6.43M | EPS | -2.19 | P/E | -0.20 | Forward P/E | N/A |
| Beta | 0.72 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.42 | 200-d Avg | 0.54 | 1yr Est | 0.00 |
OSRH News
Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-mark
Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. T
Effective June 11, 2026, OSR Health, Inc. (formerly OSR Holdings, Inc.) (the "Company") chan
OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare holding company focused on innovative therapeu
OSR Holdings (NASDAQ:OSRH) reported quarterly losses of $(0.09) per share which beat the analyst con
A Clear Commitment: No Reverse Stock SplitBELLEVUE, WA / ACCESS Newswire / May 12, 2026 / As many of
Qualcomm shares rose 10.6% in pre-market trading after reporting better-than-expected Q2 results. Ot
OSR Holdings shares surged 41.28% after securing a global exclusive licensing deal for its Phase 3-r
OSR Holdings, Inc. (NASDAQ:OSRH) today announced that it has entered into a definitive global exclus
OSR Holdings, Inc. (NASDAQ:OSRH) ("OSR Holdings" or the "Company") today announced a
Entry into a Material Definitive Agreement On March 27, 2026, OSR Holdings, Inc. (the "Company&#
OSR Holdings (NASDAQ:OSRH) reported quarterly losses of $(0.16) per share which missed the analyst c
